Eating disorders are frequently underreported because of shame or the belief that the disorder is "in the past." A complete medical history including your relationship with eating, body shape concerns, and food is essential before any GLP-1 decision is made
Glucagon-Like Peptide-1 Increases cAMP But Fails to Augment Contraction in Adult Rat Cardiac Myocytes
Pancreas GLP-1 and GIP stimulate insulin secretion GLP-1 suppresses glucagon secretion during hyperglycemia GIP suppresses glucagon secretion during hyperglycemia and stimulates secretion during euglycemia and hypoglycemia Brain GLP-1 and GIP suppress hunger Stomach GLP-1 slows gastric emptying Fat tissue GIP increases fatty acid and glucose uptake by fat tissue [1,2,3] Tirzepatide Tirzepatide is a dual GLP-1 / GIP receptor agonist that mimics the actions of GLP-1 and GIP
The commonest conditions reported were psoriasis (17.4%), non-melanoma skin cancer (10.8%), infection of the skin (6.7%), hand eczema (6.2%), acne (6.2%), nevi (5.0%), atopic dermatitis (4.5%), benign skin tumors (4.2%), and eczema (contact dermatitis) (4.1%)
Thats one of the fastest ways to get your blood sugar back up, he says
As always, consulting healthcare providers about combination therapies is essential for the best outcomes